摘要
目的:探讨红花注射液与酚妥拉明治疗肺心痛急性加重期的疗效和安全性。方法:符合肺心病诊断的40例患者,随机分为治疗组和对照组,对照组为常规治疗组,治疗组在常规治疗的基础上加用红花注射液10~15ml+5%GS250ml静滴,1次/d,连用14d;酚妥拉明10mg+5%GS250ml静滴,15—20滴/min,1次/d,连用5~7d,治疗前后行血气和血液流变学检测,2周后判定疗效。结果:治疗前两组血液流变学和血气分析均无差异,治疗后治疗组明显改善,两组疗效比较,有显著差异(P〈0.05)。结论:红花、酚妥拉明合用疗效好,副作用少。
Objective : To study the effect and safety of safflower injection and phentolamine in treating severe acute pulmonary heart disease. Method : 40 cases were divided into treating group and comparing group randomly. The comparing group were adopted the routine method. In the treating group , 10 - 15 ml safflower injection and 250ml 5% GS were taken intravenous infusion in addition to the routine method . Once a day for 14 days 250ml 5% GS and 10mg phetolamine were taken intravenous infusion with 15 - 20drip/min for 5 -7 days once a day. The sap and haemorheology were detected before and after the treatment . and then evaluate the effect 2 weeks later. Result: There' s no difference on haemorheology and sap before treatment in both groups. It was improved after treatment in treating group. There' s significant difference comparing the both groups ( p 〈 0.05 ) o Conclusion : It' s effective and with little side effect for the combination of safflower and phentolamine.
出处
《河北医学》
CAS
2006年第2期142-143,共2页
Hebei Medicine
关键词
红花
酚妥拉明
肺心病
Safflower
Phentolamine
Puhnonary heart disease